RUNX2 and colorectal carcinoma: Collectively, from our integrative analysis, we noticed the significant deregulation of specific members of the RUNX TF family at DNA (RUNX1) or mRNA (RUNX2) levels, supporting their emerging role as prognostic biomarkers in CRC [108].